ORPN Stock Chart

Bioblast Pharma Ltd. built on the premise of discovering, developing, and delivering clinically meaningful therapies for patients with rare diseases. Given the interest in the scientific and medical community regarding alternative therapeutic uses of the Company's lead drug candidate, trehalose 90 mg/mL IV solution, Bioblast has decided to concentrate internal development efforts exclusively on trehalose.